Welcome to NCSH Sexual Health in the News. This weekly online digest was created to keep you up-to-date on sexual health topics currently trending in the media.The NCSH does not endorse specific content or research included in these articles.
Despite greater access to health insurance, many people of color are still not taking advantage of preventive sexual health services. Christian Thrasher and Dr. Yolanda Wimberly of the Morehouse School of Medicine discuss how to address this disparity.
Dr. Yolanda Wimberly of the Morehouse School of Medicine spoke with the Tom Joyner Morning Show about the importance of sexual health for the African American community.
Thanks to the sex-tech revolution more people are having sex without knowledge of a partner's name and sexual history, which can lead to increased rates of STDs.
Ryan Clary of the National Viral Hepatitis Roundtable discusses the obstacles facing those with hepatitis C. Currently, one out of every 100 Americans is living with hepatitis C, yet most can't access the cure which will save their lives and halt the disease's lethal trajectory.
On Tuesday, the US Food and Drug Administration approved flibanserin, which will be sold as Addyi, for the treatment of sexual dysfunction in premenopausal women.
A study published in the Journal of Sexual Medicine found that men who reported having trouble maintaining an erection while using a condom were also likely to have "erectile difficulties" when a condom wasn't around.
Young women are risking their health by not talking about their sexual health with their doctors, claims a latest report released by Ovarian Cancer Action.
A showdown between two states and the Obama administration over eliminating Planned Parenthood's status as a Medicaid provider could leave thousands of women without access to reproductive care.
Our perception of HIV/AIDS has changed since the disease emerged in the early 1980s. Two survivors, from two different generations, tell their stories.
According to a new US study, women who choose IUDs for long-acting reversible contraception (LARC) tend to keep the devices over several years, suggesting they're satisfied with that method.
